Is Pragrel an Indian?

Pragrel is not Indian. According to relevant information, Pragley was jointly developed by Sankyo Company of Japan and EliLilly Company of the United States, and was approved for marketing by the European Union on February 23, 2009, for the treatment of atherosclerosis and acute coronary syndrome.